Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.

Abstract

BACKGROUND Salvage brachytherapy is a treatment option for patients with locally recurrent prostate cancer after primary radiation therapy. We reviewed our experience using low-dose-rate (LDR) or high-dose-rate (HDR) brachytherapy to compare the outcome and toxicity profiles of each approach in the salvage brachytherapy setting. METHODS AND MATERIALS… (More)
DOI: 10.1016/j.brachy.2017.07.013

Topics

Cite this paper

@article{Kollmeier2017SalvageBF, title={Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.}, author={Marisa A. Kollmeier and Sean Matthew McBride and Amandeep S Taggar and Erik S. Anderson and Mary Lin and Xin Wu Pei and Shi Weiji and Laszlo Voros and Gilad N Cohen and Yoshiya Josh Yamada and Michael J Zelefsky}, journal={Brachytherapy}, year={2017}, volume={16 6}, pages={1091-1098} }